Opioid-Induced Hyperalgesia

Journal of Perianesthesia Nursing

Volumn 27, Issue 1, 2012, Pages 46-50

  Pasero, Chris ^a   McCaffery, Margo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; HUMAN; HYPERALGESIA;

ANALGESICS, OPIOID; HUMANS; HYPERALGESIA;

EID: 84855995554     PISSN: 10899472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jopan.2011.11.002     Document Type: Article

References (17)

1. Pasero C., Quinn T.E., Portenoy R.K., et al. Opioid analgesics. Pain Assessment and Pharmacologic Management 2011, 277-622. Mosby/Elsevier, St. Louis, MO. C. Pasero, M. McCaffery (Eds.).
2. Compton P. The OIH paradox: Can opioids make pain worse? Pain treatment topics. Available at: 2008. Accessed October 24, 2011. http://pain-topics.org/pdf/Compton-OIH-Paradox.pdf.
3. Chu L.F., Clark D., Angst M.S. Molecular basis and clinical implications of opioid tolerance and opioid-induced hyperalgesia. Acute Pain Management 2009, 114-143. Cambridge University Press, Cambridge, NY. R.S. Sinatra, O.A. de Leon-Casasola, B. Ginsberg, E.R. Viscusi (Eds.).
4. Raffa R.B., Pergolizzi J.V. Opioid-induced hyperalgesia: Is it clinically relevant for the treatment of pain patients?. Pain Manag Nurs 2012, [in press].
5. Chu L.F., Angst M.S., Clark D. Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clin J Pain 2008, 24:479-496.
6. Chu L.F., Clark K.J., Angst M.S. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain 2006, 7:43-48.
7. DuPen A., Shen D., Ersek M. Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Manag Nurs 2007, 8:113-121.
8. Mitra S. Opioid-induced hyperalgesia: Pathophysiology and clinical implications. J Opioid Manage 2008, 4:123-130.
9. Forero M., Chan P.S., Restrepo-Garces C.E. Successful reversal of hyperalgesia/myoclonus complex with low-dose ketamine. Pain Pract June 16, 2011, [e-pub ahead of print].
10. Richebe P., Pouquet O., Jelacic S., et al. Target-controlled dosing of remifentanil during cardiac surgery reduces postoperative hyperalgesia. J Cardiothorac Vasc Anesth 2011, 25:917-925.
11. Pasero C., Portenoy R.K. Neurophysiology of pain and analgesia and the pathophysiology of neuropathic pain. Pain Assessment and Pharmacologic Management 2011, 1-12. Mosby/Elsevier, St. Louis, MO. C. Pasero, M. McCaffery (Eds.).
12. Weissman D.E., Haddox J.D. Opioid pseudoaddiction-An iatrogenic syndrome. Pain 1989, 36:363-366.
13. Mueller M.E., Golembiewski J. The changing landscape of perioperative pain management. J Perianesth Nurs 2011, 290-293.
14. Pasero C., Polomano R.C., Portenoy R.K., et al. Adjuvant analgesics. Pain Assessment and Pharmacologic Management 2011, 623-818. Mosby/Elsevier, St. Louis, MO. C. Pasero, M. McCaffery (Eds.).
15. Ramaasubbu C., Gupta A. Pharmacological treatment of opioid-induced hyperalgesia: A review of the evidence. J Pain Palliat Care Pharmacother 2011, 25:219-230.
16. Miaskowski C., Mack K.A., Dodd M.J., et al. Oncology outpatients with pain from bone metastasis require more than around-the-clock dosing of analgesics to achieve adequate pain control. J Pain 2002, 3:12-20.
17. Troster A., Sittl R., Singler B., et al. Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology 2006, 105:1016-1023.